References
- Lipsky P E., Ziff M. Inhibition of antigen and mitogen-induced human lymphocyte proliferation by gold compounds. J. Clin. Invest. 1977; 59: 455
- Lies R B., Cardin C, Paulus HE. Inhibition by gold of human lymphocyte stimulation: an in vitro study. Ann. Rheum. Dis. 1977; 36: 216
- Harth M., Stiller CR., Sinclair NR., Evans J., McGirr D., Zuberi R. Effects of a gold salt on lymphocyte responses. Clin. Exp. Immunol. 1977; 27: 357
- Hassan J, Hanly J, Bresnihan B, Freighery C, Whelan CA. The immunological consequences of gold therapy: a prospective study in patients with rheumatoid arthritis. Clin. Exp. Immunol. 1986; 63: 614
- Farrar J J., Benjamin W R., Hilfiker M L., Howard M, Farrar W L., Fuller-Farrar J. The biochemistry, biology and role of Interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses. Immunological Rev. 1982; 63: 129
- Wakasugi H, Bertoglio J, Tursz T, Fradelizi T. IL 2 receptor induction on human T lymphocytes: role for IL 2 and monocytes. J. Immunol. 1985; 135: 321
- Boyurn A. Isolation of mononuclear cells and granulocytes from human blood. Scan. J. Clin. Lab. Invest 1968; 21: 77, (Suppl 97)
- Yam L T., Li C Y., Crosby WH. Cytochemical identification of monocytes and granulocytes. Am. J. Clin. Pathol. 1971; 55: 283
- Baker P, Gillis S, Smith KA. Monoclonal cytolytic T-cell lines. J. Exp. Med. 1979; 149: 273
- Gillis S, Fern M M., Ou W, Smith KA. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol 1978; 120: 2027
- Snedecor G W., Cochran WG. Statistical methods. 7th ed. Iowa State University Press, Ames 1980; 135–146; 214–237; 385–388
- Colquhoun D. Lectures on biostatistics. Clarendon Press, Oxford 1971; 200–210
- Cantrell D A., Smith KA. Transient expression of Interleukin 2 receptors. J. Exp. Med. 1983; 158: 1895
- Depper J M., Leonard W J., Waldmann T A., Greene WC. A monoclonal antibody which recognizes the human receptor for T cell growth factor: functional effects and use as a probe to investigate receptor regulation. Lymphokines, 9, E Pick, M Landy. Academic Press, Orlando 1984; 127–152
- Drakes M L., Harth M, Galsworthy S B., McCain GA. Effects of gold on the production of, and response to Interleukin-1. J. Rheumatol., in press
- Rubinstein H M., Dietz AA. Serum gold. II. Levels in rheumatoid arthritis. Ann. Rheum. Dis. 1973; 32: 128
- Vernon Roberts B, Dore J L., Jessop J D., Henderson WJ. Selective concentration and localiration of gold in macrophages and other tisues during and after chrysotherapy in rheumatoid patients. Ann. Rheum. Dis. 1976; 35: 477
- Wilkins J A., Warrington R J., Sigurdson S L., Rutherford WJ. The demonstration of an Interleuken-2 like activity in the synovial fluids of rheumatoid arthritis patients. J. Rheumatol. 1983; 10: 109
- Emery P, Panayi G S., Nouri A ME. Interleukin-2 reverses deficient cell mediated immune responses in rheumatoid arthritis. Clin. Exp. Immunol. 1984; 57: 123
- Combe B, Pope R M., Fischbach M, Darnell B, Talal N. Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin. Exp. Immunol. 1985; 59: 520
- Lemm G, Warnatz H. Evidence for enhanced interleukin-2 (IL-2) secretion and IL-2 receptor presentation by synovial fluid lymphocytes in rheumatoid arthritis. Clin. Exp. Immunol 1986; 64: 71
- Shore A, Jaglal S, Keystone EC. Enhanced Interleukin-1 generation by monocytes in vitro is temporarily linked to an early event in the onset or exacerbation of rheumatoid arthritis. Clin. Exp. Immunol. 1985; 65: 293